These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 38453817)
1. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer. Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F Clin Transl Oncol; 2024 Aug; 26(8):2047-2059. PubMed ID: 38453817 [TBL] [Abstract][Full Text] [Related]
2. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer. Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Yang XQ; Chen C; Wang FB; Peng CW; Li Y Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276 [TBL] [Abstract][Full Text] [Related]
5. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Wang W; Chen XL; Zhao SY; Xu YH; Zhang WH; Liu K; Chen XZ; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK Oncotarget; 2016 Jun; 7(23):35423-36. PubMed ID: 27097114 [TBL] [Abstract][Full Text] [Related]
7. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study. Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500 [TBL] [Abstract][Full Text] [Related]
8. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
11. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102 [TBL] [Abstract][Full Text] [Related]
12. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study. Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967 [TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms]. Chen L; Zhang Y; Chen M; Chen J Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection. Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887 [TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer. Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155 [TBL] [Abstract][Full Text] [Related]
16. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
17. Effects of tumor marker regression load score on long-term prognosis of gastric cancer patients undergoing radical surgery after neoadjuvant chemotherapy. Zhang LK; Zheng HL; Zheng HH; Ma YB; Lin JX; Xu BB; Xue Z; Zheng ZW; Zheng CH; Huang CM; Xie JW Eur J Surg Oncol; 2024 Jun; 50(6):108367. PubMed ID: 38718701 [TBL] [Abstract][Full Text] [Related]
18. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer. Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077 [TBL] [Abstract][Full Text] [Related]
19. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma. Xu HX; Li S; Wu CT; Qi ZH; Wang WQ; Jin W; Gao HL; Zhang SR; Xu JZ; Liu C; Long J; Xu J; Ni QX; Yu XJ; Liu L Pancreatology; 2018 Sep; 18(6):671-677. PubMed ID: 30153903 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy. Huo YR; Huang Y; Liauw W; Zhao J; Morris DL Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]